
Dover (DOV) Stock Forecast & Price Target
Dover (DOV) Analyst Ratings
Bulls say
Dover has demonstrated resilient performance, with organic sales growth figures of 0.5% and 0.9% in consecutive quarters, indicating stability in its revenue stream despite slight misses against estimates. The company's bookings have shown a robust upward trend, increasing 8% in the third quarter, primarily fueled by strong demand in biopharma and sustainability technologies, suggesting a positive trajectory for future revenue generation. Additionally, Dover has experienced a significant expansion in adjusted EBITDA margins, up 480 basis points from 2018 to 2024, alongside a strategic shift towards less cyclical products and an increased focus on growth areas such as Pumps & Process and Clean Energy.
Bears say
The financial analysis indicates a negative outlook on Dover's stock due to several fundamental issues, including a disappointing backlog-to-billings (BTB) ratio of 0.98x, which fell short of expectations. Furthermore, the company's organic sales performance has been weak across multiple segments, with the Clean Energy segment reporting a decline of 5.1% and the Engineered Products segment declining by 7.0%. Additionally, the company's trading multiples show a significant discount to peers, currently at 17.1x 2026 EPS estimates, highlighting concerns regarding its market valuation amid challenges in global industrial demand and issues with M&A integration.
This aggregate rating is based on analysts' research of Dover and is not a guaranteed prediction by Public.com or investment advice.
Dover (DOV) Analyst Forecast & Price Prediction
Start investing in Dover (DOV)
Order type
Buy in
Order amount
Est. shares
0 shares